Search

Author/Creator Yu, Margaret K

1. Abiraterone acetate and prednisolone for metastatic castration‐resistant prostate cancer failing androgen deprivation and docetaxel‐based chemotherapy: A phase II bridging study in Korean and Taiwanese patients. (6th August 2014)

Authors:
Kwak, Cheol; Wu, Tony Tong Lin; Lee, Hyun Moo; Wu, Hsi Chin; Hong, Sung Joon; Ou, Yen Chuan; Byun, Seok Soo; Rhim, Hyou Young; Kheoh, Thian; Wan, Ying; Yeh, Howard; Yu, Margaret K; Kim, Choung Soo
Journal:
International journal of urology
Issue:
Volume 21:Number 12(2014)
Page Start:
1239
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study. Issue 2 (February 2015)

Authors:
Ryan, Charles J; Smith, Matthew R; Fizazi, Karim; Saad, Fred; Mulders, Peter F A; Sternberg, Cora N; Miller, Kurt; Logothetis, Christopher J; Shore, Neal D; Small, Eric J; Carles, Joan; Flaig, Thomas W; Taplin, Mary-Ellen; Higano, Celestia S; de Souza, Paul; de Bono, Johann S; Griffin, Thomas W; ...
Journal:
Lancet oncology
Issue:
Volume 16:Issue 2(2015:Feb.)
Page Start:
152
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study. Issue 2 (February 2015)

Authors:
Ryan, Charles J; Smith, Matthew R; Fizazi, Karim; Saad, Fred; Mulders, Peter F A; Sternberg, Cora N; Miller, Kurt; Logothetis, Christopher J; Shore, Neal D; Small, Eric J; Carles, Joan; Flaig, Thomas W; Taplin, Mary-Ellen; Higano, Celestia S; de Souza, Paul; de Bono, Johann S; Griffin, Thomas W; ...
Journal:
Lancet oncology
Issue:
Volume 16:Issue 2(2015:Feb.)
Page Start:
152
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Effect of apalutamide on health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: an analysis of the SPARTAN randomised, placebo-controlled, phase 3 trial. Issue 10 (October 2018)

Authors:
Saad, Fred; Cella, David; Basch, Ethan; Hadaschik, Boris A; Mainwaring, Paul N; Oudard, Stéphane; Graff, Julie N; McQuarrie, Kelly; Li, Susan; Hudgens, Stacie; Lawson, Joe; Lopez-Gitlitz, Angela; Yu, Margaret K; Smith, Matthew R; Small, Eric J
Journal:
Lancet oncology
Issue:
Volume 19:Issue 10(2018)
Page Start:
1404
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗